Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genmab A/S
Change in Working Capital Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Change in Working Capital
-kr150m
CAGR 3-Years
N/A
CAGR 5-Years
-40%
CAGR 10-Years
2%
Zealand Pharma A/S
CSE:ZEAL
Change in Working Capital
kr130m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascendis Pharma A/S
NASDAQ:ASND
Change in Working Capital
-€147.4m
CAGR 3-Years
-285%
CAGR 5-Years
N/A
CAGR 10-Years
-53%
B
Bavarian Nordic A/S
CSE:BAVA
Change in Working Capital
-kr1.1m
CAGR 3-Years
86%
CAGR 5-Years
33%
CAGR 10-Years
41%
F
Fluoguide AS
STO:FLUO
Change in Working Capital
kr10.6m
CAGR 3-Years
-2%
CAGR 5-Years
190%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Change in Working Capital
kr1.3m
CAGR 3-Years
-47%
CAGR 5-Years
-32%
CAGR 10-Years
-4%

See Also

What is Genmab A/S's Change in Working Capital?
Change in Working Capital
-150m DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Change in Working Capital amounts to -150m DKK.

What is Genmab A/S's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
2%

Over the last year, the Change in Working Capital growth was 89%.

Back to Top